Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma - propranolol hydrochloride - filmtablette - 40 mg - propranolol hydrochloride 40 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - propranolol hydrochloride - tablette - 40 mg - propranolol hydrochloride 40 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - propranolol hydrochloride - hartkapsel, retardiert - 160 mg - propranolol hydrochloride 160 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium - propranolol hydrochloride - hartkapsel mit veränderter wirkstofffreisetzung - 80 mg - propranolol hydrochloride 80 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atnahs pharma netherlands - propranolol hydrochloride - tablette - 40 mg - propranolol hydrochloride 40 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atnahs pharma netherlands - propranolol hydrochloride - tablette - 10 mg - propranolol hydrochloride 10 mg - propranolol

Europäische Union - Deutsch - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

atnahs pharma netherlands b.v. - propranolol hydrochlorid - propranolol

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

atnahs pharma netherlands b.v. - propranolol hydrochlorid - propranolol